The hottest trials and data revealed at this year’s ADA Symposium | The latest ADA Standards of Care and CVOT/DKD treatment algorithm updates | Recent updates on the SGLT2 inhibitors: CHF and renal protection | High dose GLP1-RAs, dual and triple agonists in development | Advances in drug delivery systems | The latest in CGM, pumps, hybrid closed looped and fully closed AP systems | TIR and other analytics that have and will become important | Advances in pramlintide formulations, glucagon, including glucagon receptor antagonists | Cure based immune therapies for T1D | Telehealth/digital diabetes care apps